1-3 of 3
Francesco Albano, MD, PhD
Close
Sort by
Journal Articles

MicroRNAs as the Target of Deletions on der(9) in Chronic Myeloid Leukemia.

Francesco Albano, MD, PhD, Luisa Anelli, PhD, Antonella Zagaria, PhD, Alessandra Pannunzio, PhD, Antonella Russo Rossi, MD, Floriana Manodoro, PhD, Vincenzo Liso, MD, Mariano Rocchi, PhD, Giorgina Specchia, MD
Journal: Blood
Blood (2007) 110 (11): 2926.
https://doi.org/10.1182/blood.V110.11.2926.2926
Published: 2007
Journal Articles

Downregulation of Receptor Activator of Nuclear Factor kB Ligand (RANKL) in Chronic Myeloid Leukemia Patients Receiving Imatinib Mesylate Is Dose-Dependent.

Francesco Albano, MD, PhD, Antonella Zagaria, PhD, Luisa Anelli, PhD, Maria Guastadisegni, PhD, Alessandra Pannunzio, PhD, Giuseppina Spinosa, MD, Mariano Rocchi, PhD, Vincenzo Liso, MD, Giorgina Specchia, MD
Journal: Blood
Blood (2006) 108 (11): 4786.
https://doi.org/10.1182/blood.V108.11.4786.4786
Published: 2006
Journal Articles

Receptor Activator of Nuclear Factor kB (RANK) Is Upregulated in Chronic Myeloid Leukemia Patients Taking Imatinib Mesylate: Can This Be Considered a Drug-Mediated Immune Activation Effect?.

Francesco Albano, MD, PhD, Luisa Anelli, PhD, Antonella Zagaria, PhD, Maria Guastadisegni, PhD, Alessandra Pannunzio, PhD, Vincenzo Liso, MD, Mariano Rocchi, PhD, Giorgina Specchia, MD
Journal: Blood
Blood (2006) 108 (11): 4790.
https://doi.org/10.1182/blood.V108.11.4790.4790
Published: 2006